The prevalence of serum antibody to human herpesvirus 8 (Kaposi sarcoma- associated herpesvirus) among HIV-seropositive and high-risk HIV-seronegative women

JAMA

Volumn 277, Issue 6, 1997, Pages 478-481

  Kedes, Dean H ^a   Ganem, Don ^a,c   Ameli, Niloufar ^b   Bacchetti, Peter ^b   Greenblatt, Ruth ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY;

ADULT; ARTICLE; CANCER RISK; CONTROLLED STUDY; FEMALE; HERPES SIMPLEX VIRUS; HERPES VIRUS INFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SEROPREVALENCE;

EID: 0031019761     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.277.6.478     Document Type: Article

References (30)

1. Beral V. Epidemiology of Kaposi's sarcoma. In: Beral V, Jaffe HW, Weiss R, eds. Cancer, HIV and AIDS. Cold Spring Harbor, NY: Cold Spring Harbor Press; 1991:5-22.
2. Penn I. Kaposi's sarcoma in organ transplant recipients. Transplantation. 1979;27:8-11.
3. Ziegler J, Templeton AC, Voegel GL. KS: a comparison of classical, endemic and epidemic forms. Semin Oncol. 1984;11:47-52.
4. Franceschi S, Rezza G, Serraino D, Lepri AC, Geddes M, Cote T. Risk for Kaposi's sarcoma among Italian women with AIDS. J Acquir Immune Defic Syndr. 1995;9:313-314.
5. Serraino D, Franceschi S, Maso LD, Vecchia CL. HIV transmission and Kaposi's sarcoma among European women. AIDS. 1995;9:971-973.
6. Rabken CS, Biggar RJ, Baptiste MS, Abe T, Kohler BA, Nasca PC. Cancer incidence trends in women at high risk of human immunodeficiency virus (HIV) infection. Int J Cancer. 1993;55:208-212.
7. Morlat P, Parneix P, Douard D, et al. Women and HIV infection: a cohort study of 483 HIV-infected women in Bordeaux, France, 1985-1991. AIDS. 1992; 6:1187-1193.
8. Albrecht H, Helm EB, Plettenberg A, et al. Kaposi's sarcoma in HIV infected women in Germany: more evidence for sexual transmission: a report of 10 cases and review of the literature. Genitourin Med. 1994;70:394-398.
9. Beral V, Peterman T, Berlelman R, Jaffe H. Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? Lancet. 1990;335:123-127.
10. Friedman-Kien AE, Saltzman BR, Cao YZ, et al. Kaposi's sarcoma in HIV-negative homosexual men. Lancet. 1990;335:168-169.
11. Ambroziak J, Blackbourn D, Herndier B, et al. Herpesvirus-like sequences in HIV-infected and un-infected Kaposi's sarcoma patients. Science. 1995; 268:582-583.
12. Chang Y, Cesarman E, Pessin M, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science. 1994;266:1865-1869.
13. Moore P, Chang Y. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma lesions from persons with and without HIV infection. N Engl J Med. 1995;332:1181-1185.
14. Schalling M, Ekman M, Kaaya E, Linde A, Bieberfeld P. A role for a new herpesvirus (KSHV) in different forms of Kaposi's sarcoma. Nat Med. 1995;1: 707-708.
15. Chuck S, Grant R, Katongole-Mbidde E, Conant M, Ganem D. Frequent presence of a novel herpesvirus genome in lesions of human immunodeficiency virus-negative Kaposi's sarcoma. J Infect Dis. 1996; 173:248-251.
16. Huang Y-Q, Li JJ, Kaplan MH, et al. Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma. Lancet. 1995;345:759-761.
17. Whitby D, Howard M, Tenent-Flowers M, et al. Detection of Kaposi's sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet. 1995; 346:799-802.
18. Moore P. Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma. AIDS. 1995;10:175-180.
19. Kedes D, Operskalski E, Busch M, Kohn R, Flood J, Ganem D. The seroepidemiology of human herpesvirus 8(Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nat Med. 1996;2:918-924.
20. Gao S-J, Kingsley L, Li M, et al. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med. 1996;2:925-928.
21. Lennette ET, Blackbourn DJ, Levy JA. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients. Lancet. 1996;348:858-861.
22. Simpson GR, Schulz TF, Whitby D, et al. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet. 1996;348:1133-1138.
23. Renne R, Zhong W, Herndier B, et al. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat Med. 1996;2: 342-346.
24. Mehta CR, Patel NR, Gray R. Computing an exact confidence interval for the common odds ratio in several 2×2 contingency tables. J Am Stat Assoc. 1985;78:969-973.
25. Jacobson LP, Armenian HK. An integrated approach to the epidemiology of Kaposi's sarcoma. Curr Opin Oncol. 1995;7:450-455.
26. Geddes M, Franceschi S, Barchielle A, et al. Kaposi's sarcoma in Italy before and after the AIDS epidemic. Br J Cancer. 1993;69:333-336.
27. Monini P, Lellis LD, Fabris M, Rigolin F, Cassai E. Kaposi's sarcoma-associated herpesvirus DNA sequences in prostate tissue and human semen. N Engl J Med. 1996;334:1168-1172.
28. Lin J-C, Lin S-C, Mar E-C, et al. Is Kaposi's sarcoma-associated herpesvirus detectable in the semen of HIV-infected homosexual men? Lancet. 1995; 346:1601-1602.
29. Corbellino M, Bestetti G, Galli M, Parravicini C. Absence of HHV-8 in prostate and semen. N Engl J Med. 1996;335:1237.
30. Tasaka T, Said JW, Koeffler HP. Absence of HHV-8 in prostate and semen. N Engl J Med. 1996; 335:1237-1238.